ATE177010T1 - Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie - Google Patents

Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie

Info

Publication number
ATE177010T1
ATE177010T1 AT92903516T AT92903516T ATE177010T1 AT E177010 T1 ATE177010 T1 AT E177010T1 AT 92903516 T AT92903516 T AT 92903516T AT 92903516 T AT92903516 T AT 92903516T AT E177010 T1 ATE177010 T1 AT E177010T1
Authority
AT
Austria
Prior art keywords
vaccines
against swine
immune boosting
swine pleuropneumonia
pleuropneumonia
Prior art date
Application number
AT92903516T
Other languages
English (en)
Inventor
Krishnaswamy Iyengar Dayalu
Nathan Zygraich
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE177010T1 publication Critical patent/ATE177010T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92903516T 1990-12-19 1991-12-19 Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie ATE177010T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63100990A 1990-12-19 1990-12-19

Publications (1)

Publication Number Publication Date
ATE177010T1 true ATE177010T1 (de) 1999-03-15

Family

ID=24529423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92903516T ATE177010T1 (de) 1990-12-19 1991-12-19 Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie

Country Status (9)

Country Link
EP (1) EP0563288B1 (de)
JP (1) JPH06503351A (de)
KR (1) KR100258772B1 (de)
AT (1) ATE177010T1 (de)
AU (1) AU662116B2 (de)
CA (1) CA2098719A1 (de)
DE (1) DE69130953T2 (de)
DK (1) DK0563288T3 (de)
WO (1) WO1992011023A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995025742A1 (en) * 1994-03-22 1995-09-28 Pfizer Inc. Pasteurellaceae antigens and related vaccines
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2029219B (en) * 1978-08-24 1982-12-15 Gilmour N Pasteurellosis vaccines
GB2202851B (en) * 1987-03-24 1990-12-19 Nat Res Dev Proteinaceous material of p. haemolytica and vaccine against pasteurella
NL8802007A (nl) * 1988-08-12 1990-03-01 Centraal Diergeneeskundig Inst Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
DE69110082T2 (de) * 1990-04-20 1995-11-09 Akzo Nobel Nv Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.

Also Published As

Publication number Publication date
EP0563288B1 (de) 1999-03-03
WO1992011023A1 (en) 1992-07-09
EP0563288A4 (en) 1994-08-24
DK0563288T3 (da) 1999-09-27
DE69130953D1 (de) 1999-04-08
KR930703006A (ko) 1993-11-29
JPH06503351A (ja) 1994-04-14
DE69130953T2 (de) 1999-07-08
CA2098719A1 (en) 1992-06-20
AU9168591A (en) 1992-07-22
AU662116B2 (en) 1995-08-24
EP0563288A1 (de) 1993-10-06
KR100258772B1 (ko) 2000-08-01

Similar Documents

Publication Publication Date Title
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
CY2007016I2 (el) Εμβολιο ιου θηλωματος
ATE103315T1 (de) Verwendung haertbarer cycloaliphaten-derivate in duebelmassen.
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
MX9102145A (es) Composiciones epoxi avanzadas, composiciones curables y productos curados.
DK0789590T3 (da) Chitosaninduceret immunforstærkning
ITMI913092A0 (it) Vaccino di poxvirus ricombinate del virus del morbillo
PT625204E (pt) Terapeutica da hepatite
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
DE3882781D1 (de) Impfstoff gegen pasteurella.
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
FI925032A0 (fi) Vaccinsammansaettningar
DE69130953D1 (de) Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung
ES2082221T3 (es) Neuraminidasa y galactosa-oxidasa en calidad de adyuvante de vacunas.
ITRM910385A0 (it) Vaccini utilizzanti eritrociti come veicoli di antigeni.
NO901959L (no) Malaria-vaksine.
DE69232962D1 (de) Influenzaimpfstoff, der als sinergistischer zusatzmittel influenzavirusinnenkörper enthält
DE69228063D1 (de) Abgeschwächter rückmutierter virusimpfstoff gegen mareks krankheit serotyp-1
MX9100472A (es) Composiciones epoxi avanzadas,composiciones curables y productos curados

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties